somatic mutations [comd]
activating [acty]
PIK3CA [gngm]
Sporadic [tmco]
Venous [bpoc]
malformations [ftcn]
mice [mamm]
Humans [humn]
Venous malformation [anab]
Painful [sosy]
deforming [ftcn]
Vascular lesions [dsyn]
Dilated blood vessel [fndg]
Channel [spco]
Present [qnco]
Birth [orgf]
Mutations [genf]
TEK gene [gngm]
Encoding [idcn]
Tyrosine Kinase Receptor [aapp, enzy, rcpt]
TIE2 [gngm]
Half [qnco]
Sporadic [tmco]
Venous malformation [anab]
Remaining [qlco]
Cases [ftcn]
Unknown [qlco]
Sclerotherapy [topp]
Accepted [qlco]
First-Line Treatment [topp]
Efficient [qlco]
Targeted Therapy [topp]
Generated [acty]
Mouse Model [emod]
Mirror [mnob]
Human [humn]
Mosaic [spco]
PIK3CA [gngm]
Active [ftcn]
Mutant [comd]
p110-ALPHA [gngm]
Isoform [aapp]
Phosphatidylinositol 3-Kinase [aapp, enzy]
Embryonic [emst]
Mesoderm [emst]
Endothelial [tisu]
PIK3CA [gngm]
Endothelial cell [cell]
reduction [npop]
Pericyte [cell]
coverage [idcn]
Blood Vessels [bpoc]
Decreased [qnco]
arterio-venous [bpoc]
Specification [cnce]
Marker [clna]
Phosphatidylinositol 3-Kinase [aapp, enzy]
Pathway [moft]
Inhibition [menp]
Rapamycin [antb, orch]
Normalized [resa]
Endothelial cell [cell]
Pericyte [cell]
coverage [idcn]
Postnatal [tmco]
Retinas [bpoc]
Stimulated [npop]
Regression [patf]
In Vivo [spco]
Mouse [mamm]
Report [inpr]
activating [acty]
PIK3CA [gngm]
Mutations [genf]
Human [humn]
Venous malformation [anab]
Exclusive [idcn]
TEK [gngm]
Mutations [genf]
causality [ftcn]
Relationship [qlco]
activating [acty]
PIK3CA [gngm]
Mutations [genf]
Genesis [gngm]
Venous malformation [anab]
Model, Genetic [inpr]
Mirror [mnob]
Normal [qlco]
aetiology [ftcn]
Human [humn]
establish [qlco]
Basis [ftcn]
Phosphatidylinositol 3-Kinase [aapp, enzy]
Targeted Therapy [topp]
Venous malformation [anab]
